HPV vaccination protects against infection caused by the Human Papillomavirus (HPV), a group of viruses strongly linked with cervical cancer.
HPV infection is very common, but some high-risk types can cause cancer after persistent infection. The most important cancer-causing HPV types are HPV 16 and HPV 18, which are responsible for a major share of cervical cancer cases.
Why HPV Vaccination Matters
Cervical cancer is one of the most preventable cancers because it can be tackled through vaccination, screening and early treatment.
The World Health Organization states that cervical cancer is largely preventable through HPV vaccination and regular screening, and can be cured if detected early and treated properly. Globally, cervical cancer caused around 6.04 lakh new cases and about 2.8 lakh deaths in 2024.
HPV vaccination is most effective when given before exposure to the virus. That is why vaccination is usually targeted at adolescent girls before the age of sexual activity.
India’s HPV Vaccination Programme
India launched a nationwide free HPV vaccination programme on 28 February 2026 from Ajmer, Rajasthan. The programme targets adolescent girls for prevention of cervical cancer.
Under the national programme, vaccines are being provided free of cost at government facilities to approximately 1.15–1.2 crore eligible girls, with the main target group being 14-year-old girls across States and Union Territories.
India’s national programme uses Gardasil, a quadrivalent HPV vaccine that protects against HPV types 16 and 18, which cause cervical cancer, and HPV types 6 and 11, which are linked with genital warts.
How the Vaccine Works
The HPV vaccine trains the immune system to recognise HPV before the virus causes persistent infection.
It does not treat existing cervical cancer. It is a preventive vaccine, not a curative vaccine.
Its main purpose is to prevent future HPV infection and reduce the long-term risk of cervical cancer.
Who Should Get It
The ideal target group is adolescent girls before exposure to HPV.
In India’s current national rollout, the focus is on:
- girls aged around 14 years
- school-based and facility-based vaccination
- free vaccination through government health facilities
- awareness campaigns to reduce hesitancy
Globally, many countries vaccinate both girls and boys because HPV can also cause cancers of the anus, throat, penis, vulva and vagina. However, India’s national public programme is currently focused on girls for cervical cancer prevention.
Link with Cervical Cancer Elimination
HPV vaccination is central to the WHO’s cervical cancer elimination strategy.
The WHO strategy is often summarised as 90-70-90:
- 90% of girls fully vaccinated with HPV vaccine by age 15
- 70% of women screened with a high-performance test by age 35 and again by age 45
- 90% of women with cervical disease receiving treatment
This means vaccination alone is not enough. Screening and treatment are also essential, especially for adult women who were not vaccinated earlier.
Benefits
HPV vaccination can produce long-term public health benefits.
Important benefits include:
- reduces risk of cervical cancer
- prevents infection from high-risk HPV types
- reduces future treatment burden
- lowers cancer-related mortality
- protects girls before exposure to HPV
- reduces out-of-pocket health expenditure
- supports women’s health and reproductive health
- strengthens preventive healthcare
For India, this is especially important because cervical cancer creates a heavy burden on families, especially when diagnosis happens late.
Safety and Misconceptions
HPV vaccines have been used globally for many years and are considered safe when administered as per guidelines.
Common minor side effects may include:
- pain at injection site
- mild fever
- headache
- tiredness
- dizziness
A major misconception is that HPV vaccination affects fertility. There is no scientific basis for this claim. Public awareness is important because vaccine hesitancy can reduce coverage.
India’s Public Health Challenge
The challenge is not only vaccine availability. It is also social acceptance.
HPV is sexually transmitted, so families may hesitate to discuss it openly. Some parents may wrongly think the vaccine is unnecessary for young girls or may associate it with stigma.
Therefore, successful implementation needs:
- school-based awareness
- parent counselling
- involvement of teachers and ASHA workers
- clear messaging on cancer prevention
- myth-busting on fertility and safety
- tracking of missed beneficiaries
- integration with U-WIN and immunisation systems
Mandsaur Model Link
The Mandsaur Model is relevant because it showed how district-level planning can improve HPV vaccination coverage.
Its success came from verified beneficiary lists, school-level planning, door-to-door mobilisation, community involvement and real-time monitoring. This kind of model can help India achieve high coverage under the national HPV vaccination programme.
Significance
HPV vaccination is one of the most important preventive health interventions for women’s health in India.
It shifts cervical cancer control from late-stage treatment to early prevention.
For India, the vaccination campaign is significant because it combines:
- adolescent health
- cancer prevention
- women’s health
- public immunisation
- digital tracking
- school-based outreach
- preventive healthcare
The real impact will depend on high vaccine coverage, public trust, continued screening of adult women and timely treatment of detected cervical disease.
